Osteoarthritis Linked to Gut Microbe Imbalance, Study Finds

If you or someone you love has osteoarthritis, you have probably heard it explained as simple wear and tear on a joint. That explanation has never quite fit: plenty of people with badly worn cartilage on an X-ray feel no pain, while others with mild damage are in agony. A new study offers a biological reason why, tracing part of the disease back to the gut. Researchers found that people with osteoarthritis carry a distinctly different mix of gut bacteria and gut fungi than healthy people the same age, and that a handful of those microbes can flag the disease with notable accuracy.

Key takeaways

• Osteoarthritis (OA) patients showed disrupted gut bacteria and gut fungi, plus sharply elevated inflammatory blood markers, compared with healthy controls.
• A five-microbe panel (three gut bacteria, two gut fungi) distinguished OA patients from healthy controls with an AUC of 0.880 (a 1.0 would be a perfect test; 0.5 is a coin flip).
• The gut's bacteria and fungi normally interact closely; in OA patients that cross-talk was measurably weaker, hinting at a broader ecosystem imbalance rather than one "bad" microbe.
• This is a correlational, 58-person snapshot, not proof that gut microbes cause OA or a ready-to-use diagnostic test.

Osteoarthritis patients carry a distinct gut bacterial and fungal fingerprint

Researchers led by a team publishing in Frontiers in Cellular and Infection Microbiology compared the gut microbiota of 32 people with knee osteoarthritis to 26 healthy controls matched for age, sex, and body mass index. Using stool samples, they sequenced both the bacterial community (via 16S rRNA sequencing, a standard method for identifying bacterial species from genetic material in a sample) and, less commonly for OA research, the fungal community (via ITS sequencing, the fungal equivalent). At the phylum level, OA patients had significantly more Proteobacteria (a group that includes many inflammation-associated species) and significantly less Firmicutes and Bacteroidota, two phyla generally considered beneficial. At the genus level, potentially harmful Escherichia-Shigella and the Ruminococcus gnavus group were elevated, while several genera linked to gut health, including Faecalibacterium and Subdoligranulum, were reduced. On the fungal side, Saccharomyces and Aureobasidium were enriched in OA patients, while several other fungal genera, including Aspergillus, were depleted.

Inflammation markers were sharply elevated in osteoarthritis patients

Chronic low-grade inflammation is now considered a central driver of osteoarthritis progression, not just a side effect of joint damage. The study measured four inflammatory markers in blood serum and found all of them elevated in OA patients. The starkest difference was lipopolysaccharide (LPS), a molecule shed by certain gut bacteria that can leak into the bloodstream when the gut lining is compromised: OA patients averaged 112.70 EU/mL versus 22.09 EU/mL in healthy controls, roughly a fivefold difference. Interleukin-1β, interleukin-6, and interleukin-10, three immune-signaling proteins involved in inflammation, were also significantly higher. The researchers then statistically linked specific microbial genera to these markers: several of the bacteria depleted in OA patients, including Subdoligranulum and the Eubacterium hallii group, correlated negatively with the inflammatory markers, while genera enriched in OA correlated positively. That pattern fits the "leaky gut" idea, where a disrupted gut barrier lets bacterial byproducts like LPS reach the bloodstream and fuel inflammation throughout the body, including joints.

A five-microbe panel flagged osteoarthritis with strong diagnostic accuracy

The study's most attention-grabbing result came from testing whether specific gut microbes could distinguish OA patients from healthy people, using a statistical method called receiver operating characteristic (ROC) analysis, which scores a test's accuracy on a scale from 0.5 (no better than chance) to 1.0 (perfect). Three bacterial genera performed well individually: the Eubacterium coprostanoligenes group scored an AUC of 0.857, Subdoligranulum scored 0.800, and the Ruminococcus gauvreauii group scored 0.795. Two fungal genera, Malassezia (0.738) and Aspergillus (0.727), added moderate diagnostic value on their own. Combined into a single five-genus panel, the AUC rose to 0.880 (95% confidence interval 0.782 to 0.984), meaning the panel correctly ranked an OA patient above a healthy control roughly 88% of the time in this sample. That beat a similarly designed seven-genus bacterial panel from a separate 2021 study, which had reported an AUC around 0.834, though the two panels used different microbes and cannot be compared head to head without a shared validation cohort.

The gut's bacteria and fungi appear to lose their normal partnership in osteoarthritis

Beyond individual microbes, the researchers mapped how bacterial and fungal genera interact with each other, building separate cross-kingdom interaction networks for each group. In healthy controls, bacteria and fungi formed a dense, interconnected network with a correlation strength of 1.727. In OA patients, that same network was noticeably sparser, with a correlation strength of just 0.958, splintering into smaller isolated clusters instead of one connected web. The authors interpret this as a sign that osteoarthritis is associated with a broader loss of ecological balance in the gut, not just an increase or decrease in a few species. It is a novel angle: most prior gut-OA research has looked at bacteria alone, and this cross-kingdom network approach is one of the first to formally quantify how bacterial-fungal cooperation itself changes with disease.

What this could mean if you are managing joint pain

None of this translates into a stool test you can order today, and no supplement or probiotic tested here was shown to treat osteoarthritis. What it does add is a biological rationale for something researchers have suspected: that gut health and joint inflammation are connected, and that markers like elevated LPS may partly explain why some people's OA runs hotter and more painful than the cartilage damage alone would predict. If you already have OA and are curious whether gut health plays into your symptoms, this is a reasonable topic to raise with a doctor or rheumatologist, particularly if you also deal with digestive symptoms, since the study excluded people with inflammatory bowel disease or irritable bowel syndrome to isolate the OA-specific signal. Do not read this as license to self-treat OA with an over-the-counter probiotic; the study did not test any intervention.

The findings are preliminary and unvalidated in a second group

The authors are explicit about the limits of their own work. With only 32 OA patients and 26 controls, the study is underpowered to rule out chance findings, and the diagnostic panel was built and tested on the same small group rather than validated in an independent cohort, which the authors themselves flag as a real risk of overfitting (a model that looks accurate on the data it was built with but performs worse on new data). All participants were Han Chinese and from a single Chinese province, so it is unclear whether the same microbial signatures would hold in other populations with different diets and environments. And because this is a cross-sectional snapshot comparing two groups at one point in time, it cannot establish whether gut dysbiosis causes osteoarthritis, results from it, or both influence each other through some third factor like body weight or diet.

Researchers are already testing whether adjusting the gut microbiome helps

The paper points to a handful of early clinical trials attempting to intervene on this axis directly, including a randomized trial of an inulin-based prebiotic in knee OA patients and a trial pairing a specific probiotic strain with chondroitin sulfate in postmenopausal women with knee OA, both of which reportedly improved symptoms. Those are separate, smaller studies rather than part of this one, and none of them used the specific five-genus panel identified here. The authors' own next step is larger, prospectively recruited studies with proper external validation, the kind of work needed before any gut-based OA test or targeted probiotic could move toward clinical use.

Common questions

Does this mean gut bacteria cause osteoarthritis? Not based on this study. It found a correlation between microbial imbalance and OA, but the cross-sectional design cannot determine whether gut changes cause joint disease, result from it, or both stem from a shared factor like body weight, diet, or aging.

Is there a gut microbiome test for osteoarthritis available now? No. The five-genus panel achieved an AUC of 0.880 in this specific 58-person sample, but the authors have not validated it in an independent group, and it is not an approved or commercially available diagnostic.

Should I take a probiotic for my osteoarthritis? This study did not test any probiotic or supplement, so it cannot support that recommendation. Separate small trials cited in the paper found some symptom benefit from specific prebiotic and probiotic regimens, but those results are preliminary and involve different products than anything discussed here; talk to a doctor before starting a new supplement for a joint condition.

Why did the researchers look at gut fungi in addition to bacteria? Most prior gut-microbiome research on osteoarthritis focused only on bacteria. This team also sequenced fungi and found their community was altered too, and that the normal cooperative relationship between gut bacteria and fungi was weaker in OA patients, an angle largely unexplored in earlier research.

References

Peng Zou, Xuejian Liu, Yichong Wang, et al. (2026). Analysis of gut microbiota characteristics in osteoarthritis patients. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1915556